Emergent BioSolutions EBS
NYSE EBS
$6.29 -0.07 (-1.10%)
As of: Oct 20, 2026 · 3:59 PM EDT

Emergent BioSolutions (EBS) Acquisitions (2013 - 2020)

Updated

Emergent BioSolutions (EBS) reported Acquisitions of $827.7 million for FY2018, up 604.4% from $117.5 million in FY2017.

Analysis

Emergent BioSolutions (EBS) Acquisitions (2013 - 2020) Analysis & Trends

Dating back to FY2010, Emergent BioSolutions' Acquisitions record includes 6 years.

  • Acquisitions has a five-year compound annual growth rate of 100.0% (FY2013 to FY2018).
  • The FY2018 figure ranks as the highest annual Acquisitions in data going back to FY2010.
  • According to Business Quant data, Acquisitions came in at $117.5 million in FY2017, $650,000 in FY2015 (-99.6%) and $179.38 million in FY2014 (+593.3%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 8.75 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn -17.24 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn -
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn -
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 23.00 Mn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn -
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn -
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 11.21 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn -
10 Emergent BioSolutions 325.34 Mn -425.56 Mn 137.20 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 -10.00 Mn
Dec 31, 2019 -10.00 Mn
Dec 31, 2018 827.70 Mn
Dec 31, 2015 650,000.00
Dec 31, 2014 1.21 Mn
Mar 31, 2014 178.17 Mn
Dec 31, 2013 1.75 Mn
Sep 30, 2013 24.12 Mn
API Access

Emergent BioSolutions Acquisitions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=acquisitions&ticker=EBS&period=max&api_key=YOUR_API_KEY